Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapies
Open Access
- 10 February 1995
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 56 (11-12), 869-876
- https://doi.org/10.1016/0024-3205(95)00022-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mutational analysis of muscarinic acetylcholine receptors: Structural basis of ligand/receptor/g protein interactionsLife Sciences, 1993
- Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in alzheimer's diseaseLife Sciences, 1993
- Distinct kinetic binding propeties of N‐[3H]‐methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brainSynapse, 1993
- Molecular pathology of Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Coupling of muscarinic receptors to GTP proteins in postmortem human brain — alterations in Alzheimer's diseaseNeuroscience Letters, 1993
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992
- Loss of high‐affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapiesAnnals of Neurology, 1991
- Bacterial expression of human muscarinic receptor fusion proteins and generation of subtype‐specific antiseraFEBS Letters, 1990
- Identification of a Family of Muscarinic Acetylcholine Receptor GenesScience, 1987
- Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic DenervationScience, 1985